A medication assessment tool to evaluate prescribers' adherence to evidence-based guidelines in bipolar disorder
Affiliations
Affiliations
- Department of Pharmacy Practice, Faculty of Pharmacy, Kuwait University, Jabriya, Kuwait. d.altaweel@hsc.edu.kw.
- Faculty of Medicine, Kuwait University, Jabriya, Kuwait.
- University of Toronto, Toronto, Canada.
Abstract
Background The goal of evidence-based clinical practice has led to an increased interest in the development of tools to measure adherence to national guidelines in different diseases. This aids in detecting and measuring inappropriate prescribing to specific patient groups by using quality standards extracted from evidence-based guidelines, and ultimately provide the basis of consistent standardized prescribing. Objective To design and validate a medication assessment tool to assess prescribers' adherence to international guideline recommendations in the management of bipolar disorder (MATBD). Setting Outpatient psychiatry clinic at a secondary healthcare setting in Kuwait. Method International guidelines concerned with the management of bipolar disorder were reviewed in order to develop MATBD. Face and content validity of the developed tool (MATBD) was performed with a research and expert group. A 4-point Likert scale was used to assess the expert group's level of agreement to individual criterion. Content validity ratio (CVR) was calculated for each criterion (n = 54) and the content validity index (CVI) was calculated for each section (n = 5) of the MATBD. Finally, feasibility testing was performed on 19 patient records to confirm the tool's fitness for purpose. Main Outcomes Measure Perceived relevance, utility, and clarity of individual criteria, and reliability of their application to clinical settings. Results Face validity and content validity were achieved with a research and expert group (n = 14). Content validity ratio (CVR) was demonstrated for 54 criteria; criteria with a negative CVR were removed. This resulted in a draft MATBD comprising of 52 criteria (CVI: 0.814). Feasibility testing on 19 patients' records resulted in a final MATBD comprising of 49 criteria divided into 3 sections: initial assessment, acute management and monitoring. Conclusion A medication assessment tool was developed and validated to be used as a means of profiling potential opportunities for medication therapy management optimization, and improving therapeutic interventions regarding the management of bipolar disorder.
Keywords: Bipolar disorder; Clinical guidelines; Guideline adherence; Kuwait; Medication therapy management.
Similar articles
Al-Taweel D, Awad A.PLoS One. 2020 Nov 30;15(11):e0241633. doi: 10.1371/journal.pone.0241633. eCollection 2020.PMID: 33253267 Free PMC article.
Design and validation of a medication assessment tool for cancer pain management.
HÃ¥konsen GD, Hudson S, Loennechen T.Pharm World Sci. 2006 Dec;28(6):342-51. doi: 10.1007/s11096-006-9060-4. Epub 2006 Nov 21.PMID: 17120130
Al-Taweel DM, Awad AI, Johnson BJ.Int J Clin Pharm. 2013 Apr;35(2):244-50. doi: 10.1007/s11096-012-9738-8. Epub 2012 Dec 20.PMID: 23254942
[Methodological approach to inter "guideline" variability in the management of bipolar disorders].
Samalin L, Llorca PM.Encephale. 2012 Apr;38(2):126-32. doi: 10.1016/j.encep.2011.07.004. Epub 2011 Aug 31.PMID: 22516270 Review. French.
Velligan DI, Weiden PJ, Sajatovic M, Scott J, Carpenter D, Ross R, Docherty JP; Expert Consensus Panel on Adherence Problems in Serious and Persistent Mental Illness.J Clin Psychiatry. 2009;70 Suppl 4:1-46; quiz 47-8.PMID: 19686636 Review.
Cited by
Al-Taweel D, Awad A.Front Pharmacol. 2021 Oct 4;12:647674. doi: 10.3389/fphar.2021.647674. eCollection 2021.PMID: 34671251 Free PMC article.
Al-Taweel D, Awad A.PLoS One. 2020 Nov 30;15(11):e0241633. doi: 10.1371/journal.pone.0241633. eCollection 2020.PMID: 33253267 Free PMC article.
Khawagi WY, Steinke DT, Nguyen J, Keers RN.PLoS One. 2019 May 24;14(5):e0217406. doi: 10.1371/journal.pone.0217406. eCollection 2019.PMID: 31125358 Free PMC article.
KMEL References
References
-
- Int J Clin Pharm. 2013 Apr;35(2):244-50 - PubMed
-
- JAMA. 2005 May 25;293(20):2528-30 - PubMed
-
- Arch Gen Psychiatry. 2005 Jun;62(6):629-40 - PubMed
-
- Bipolar Disord. 2013 Feb;15(1):1-44 - PubMed
-
- Curr Med Res Opin. 2007 Mar;23(3):467-75 - PubMed
-
- Psychol Med. 2005 Dec;35(12):1695-706 - PubMed
-
- Pharm World Sci. 2008 Jan;30(1):120-7 - PubMed
-
- Pharm World Sci. 2006 Dec;28(6):342-51 - PubMed
-
- Clin Psychol Rev. 2013 Feb;33(1):33-44 - PubMed
-
- Pharmacoeconomics. 2003;21(9):601-22 - PubMed
-
- Pharmacoepidemiol Drug Saf. 2011 Mar;20(3):249-57 - PubMed
-
- Arch Gen Psychiatry. 2001 Sep;58(9):844-50 - PubMed
-
- Nurse Educ Pract. 2008 Sep;8(5):299-301 - PubMed
-
- Psychiatr Danub. 2009 Jun;21(2):224-9 - PubMed
-
- J Affect Disord. 2011 Mar;129(1-3):79-83 - PubMed
-
- BMC Psychiatry. 2013 Aug 13;13:211 - PubMed
-
- PLoS One. 2014 Apr 24;9(4):e96096 - PubMed
-
- J Clin Psychiatry. 2003 Apr;64(4):370-82 - PubMed
-
- J Nerv Ment Dis. 2011 Apr;199(4):239-43 - PubMed